Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02590939 · ClinicalTrials.gov registry record · NA
Acute Treatment of Migraine With e-TNS
A NA study, sponsored by Cefaly Technology.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT02590939 is a NA study that has completed, run by Cefaly Technology. The registered enrollment target is 106 participants.
The verdict
NCT02590939, a NA study, has completed, sponsored by Cefaly Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The main objective of this study is to assess the efficacy of the Cefaly® device as an acute treatment of migraine attack in adult patients. The patients will be applied either an active or placebo external neurostimulation for 1 hour during a migraine attack, and will report the pain on a visual analog scale before and after the treatment.
Interventions
- DEVICE CEFALY Active
- DEVICE CEFALY Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2016-02-01 |
| Est. Completion | 2017-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02590939
The ClinicalTrials.gov registry entry for NCT02590939 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cefaly Technology, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CEFALY Active is the first listed.
NCT02590939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02590939 about?
NCT02590939 is a clinical study titled "Acute Treatment of Migraine With e-TNS". The main objective of this study is to assess the efficacy of the Cefaly® device as an acute treatment of migraine attack in adult patients. The patients will be applied either an active or placebo external neurostimulation for 1 hour during a migraine attack, and will report the pain on a visual an...
What is the current status of trial NCT02590939?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2016-02-01. Estimated completion is 2017-03-31.
What interventions are being tested in trial NCT02590939?
The interventions under investigation include: CEFALY Active (DEVICE), CEFALY Placebo (DEVICE).
Who is sponsoring clinical trial NCT02590939?
This trial is sponsored by Cefaly Technology, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.